Health CanadaGeneral Alert

Certain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose

Publié le: 21 juin 2023ID du rappel: 73862Catégorie: Produits de ConsommationPays: Canada
Canada
Safety AlertHealth CanadaCanadaCanada

Certain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose

Recalling Firm: Communications and Public Affairs Branch

🌐
Traduire l’alerteTranslate notice text, hazard warnings, and descriptions into any supported language.

Motif du rappel / Danger

Labelling

Description du produit & Identification

Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If you are unsure, contact your pharmacist to check if your bottle contains the correct capsules.If you see incorrect capsules, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal.Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache.Contact JAMP Pharma Corporation by email at alewicki@jamppharma.com if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.

Produits concernés

JAMP Venlafaxine XR 37.5 mg (lot PTC5140A) sold to pharmacies in bottles of 100 capsules for dispensing.

Additional Source Details

FieldValue
N I D73862
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/certain-bottles-jamp-venlafaxine-xr-375-mg-capsules-recalled-due-mislabelling-could
IssueLabelling
TitleCertain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose
ProductJAMP Venlafaxine XR 37.5 mg (lot PTC5140A) sold to pharmacies in bottles of 100 capsules for dispensing.
Archived0
CategoryDrugs
Last updated2023-06-21
OrganizationCommunications and Public Affairs Branch
What you should doCheck the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If you are unsure, contact your pharmacist to check if your bottle contains the correct capsules.If you see incorrect capsules, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal.Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache.Contact JAMP Pharma Corporation by email at alewicki@jamppharma.com if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.

Consumer Action Protocol: What You Should Do Immediately

Safety Steps
1Verify Product Identifiers

Check the model number, serial number, and date stamp on the rating label on the back or underside of the product.

2Isolate & Discontinue Use

Immediately discontinue using the product. Unplug electrical items and keep juvenile items out of reach of children.

3Claim Free Statutory Remedy

Under statutory consumer protection rules, consumers are entitled to a full refund, certified replacement, or free repair kit without needing the original sales receipt.

4Report Adverse Incidents

If you suffered an injury, illness, or property damage from this product, file an official incident report with regulatory authorities (Health Canada).

Your Legal Rights as a Consumer

Recalls are legally binding corrective safety actions overseen by statutory government bodies. Recalling entities are legally prohibited from charging consumers for official safety remedies. If a retailer or dealership refuses your recall remedy, notify the issuing regulatory agency immediately.

Frequently Asked Questions About This Recall

FAQ Guide

Q1:What should I do immediately if I own or bought Certain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose?

Immediately stop using the product and keep it out of reach of children. Disconnect power if electrical, and do not attempt makeshift home repairs.

Q2:Can I get a full refund or free repair for this recall?

Yes. Recalling manufacturers and retail merchants are required under consumer protection regulations to offer a statutory remedy—typically a full refund, certified repair kit, or replacement unit.

Q3:Do I need my original sales receipt to claim a remedy or refund?

In most recall cases, no receipt is required. Because safety recalls are matters of public health and statutory compliance, retailers and manufacturers routinely issue refunds, store credit, or replacement kits upon presentation of the affected product or lot code.

Q4:Where can I verify official information for this safety alert?

This safety alert is aggregated directly from official regulatory agency records (Health Canada). You can click the 'Official Agency Alert' link on this page to view the primary government notice and contact the manufacturer directly.

Vérifiez les autres produits de votre foyer

Outils gratuits

Safety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:

Aperçu

  • Entreprise responsableCommunications and Public Affairs Branch
Recall Hazard Severity
Caution (Class III)
Alerte officielle de l’agence

📢 Partager l’alerte

Alert family and friends to keep them safe. Copy this quick alert message:

🚨 SAFETY ALERT: Communications and Public Affairs Branch - Certain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose

Check if your household is affected:
https://therecallfile.com/fr/recalls/certain-bottles-of-jamp-venlafaxine-xr-37-5-mg-capsules-recalled-due-t/CANADA-73862
WhatsAppFacebook

Rejoindre la liste d’alerte

Recevez des alertes e-mail instantanées dès qu’un rappel critique est publié.

Support The Recall File

Help keep official recall alerts free, accessible, and fast for everyone.

Donate with PayPal

Supports USD, EUR, GBP, International Cards & PayPal

Spread the WordCertain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose

Install The Recall File App

Check safety warnings, scan your pantry, and monitor your vehicles directly from your home screen.